No acute effects of smoking and nicotine nasal spray on lipolysis measured by subcutaneous microdialysis

European Journal of Clinical Investigation

Volumn 27, Issue 6, 1997, Pages 503-509

  Eliasson, B ^a   Smith, U ^a   Lonnroth P ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Adipose tissue; Blood flow; Insulin; Lipolysis; Microdialysis; Nicotine nasal spray; Oral glucose tolerance test; Smoking

Indexed keywords

INSULIN; LACTIC ACID; NICOTINE; NOSE SPRAY;

ADIPOSE TISSUE; ADULT; ARTICLE; CARDIOVASCULAR RISK; CLINICAL ARTICLE; DYSLIPIDEMIA; HUMAN; INSULIN BLOOD LEVEL; LACTATE BLOOD LEVEL; LIPID ANALYSIS; LIPOLYSIS; MALE; MICRODIALYSIS; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; SMOKING;

EID: 0030855617     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.1997.1370689.x     Document Type: Article

References (41)

1. Rimm EB, Chan J, Stampfer MJ, Colditz GA, Willett WC. Prospective study of cigarette smoking, alcohol use, and the risk of diabetes in men. BMJ 1995;310:555-9.
2. Rimm EB, Manson JE, Stampfer MJ et al. Cigarette smoking and the risk of diabetes in women. Am J Public Health 993;83:211-14.
3. Feskens EJM, Kromhout D. Cardiovascular risk factors and the 25-year incidence of diabetes mellitus in middle-aged men. The Zutphen study. Am J Epidemiol 1989;130:1101-8.
4. Craig WY, Palomaki GE, Haddow JE. Cigarette smoking and serum lipid and lipoprotein concentrations: an analysis of published data. BMJ 1989;298:784-8.
5. Axelsen M, Eliasson B, Joheim T, Lenner R, Taskinen M-R, Smith U. Lipid intolerance in smokers. J Intern Med 1995;237:449-55.
6. Janzon L, Berntorp K, Hanson M, Lindell S-E, Trell E. Glucose tolerance and smoking: a population study of oral and intravenous glucose tolerance tests in middle-aged men. Diabetologia 1983;25:86-8.
7. Zavaroni I, Bonini L, Gasparini P, Dall'Aglio E, Passeri M, Reaven GM. Cigarette smokers are relatively glucose intolerant, hyperinsulinemic and dyslipidemic. Am J Cardiol 1994;73:904-5.
8. Facchini FS, Hollenbeck CB, Jeppesen J, Chen Y-DI, Reaven GM. Insulin resistance and cigarette smoking. Lancet 1992;339:1128-30.
9. Attvall S, Fowelin J, Lager I, von Schenck H, Smith U. Smoking induces insulin resistance - a potential link with the insulin resistance syndrome. J Intern Med 1993;233:327-32.
10. Eliasson B, Mero N, Taskinen M-R, Smith U. The insulin resistance syndrome and postprandial lipid intolerance in smokers. Atherosclerosis 1997;129:79-88.
11. Eliasson B, Attvall S, Taskinen MR, Smith U. The insulin resistance syndrome in smokers is related to smoking habits. Arterioscler Thromb 1994;14:1946-50.
12. Cryer PE, Haymond MW, Santiago JV, Shah SD. Norepinephrine and epinephrine release and adrenergic mediation of smoking-associated hemodynamic and metabolic events. N Engl J Med 1976;295:573-7.
13. Andersson K, Eneroth P, Arner P. Changes in circulating lipid and carbohydrate metabolites following systemic nicotine treatment in healthy men. Int J Obesity 1993;17:675-80.
14. Hellerstein MK, Benowitz NL, Neese RA et al. Effects of cigarette smoking and its cessation on lipid metabolism and energy expenditure in heavy smokers. J Clin Invest 1994;93:265-72.
15. Kershbaum A, Bellet S, Dickstein ER, Feinberg LJ. Effect of cigarette smoking and nicotine on serum fatty acids. Based on a study in the human subject and the experimental animal. Circ Res 1961;9:631-8.
16. Reaven GM. Role of insulin resistance in human disease. Diabetes 1988;37:1595-607.
17. Silagy C, Mant D, Fowler G, Lodge M. Meta-analysis on efficacy of nicotine replacement therapies in smoking cessation. Lancet 1994;343:139-42.
18. Tang JL, Law M, Wald N. How effective is nicotine replacement therapy in helping people to stop smoking? BMJ 1994;308:21-6.
19. Eliasson B, Taskinen M-R, Smith U. Long-term use of nicotine gum is associated with hyperinsulinemia and insulin resistance. Circulation 1996;94:878-81.
20. Lönnroth P, Jansson P-A, Smith U. A microdialysis method allowing characterization of intercellular water space in humans. Am J Physiol 1987;253:E228-31.
21. Sutherland G, Stapleton JA, Russell MAH et al. Randomised controlled trial of nasal nicotine spray in smoking cessation. Lancet 1992;340:324-9.
22. Larsen OA, Lassen NA, Quaade F. Blood flow through human adipose tissue determined with radioactive xenon. Acta Physiol Scand 1966;66:337-45.
23. Jansson PA, Larsson A, Smith U, Lönnroth P. Glycerol production in subcutaneous adipose tissue in lean and obese humans. J Clin Invest 1992;89:1610-17.
24. Jansson PA, Larsson A, Smith U, Lönnroth P. Lactate release from the subcutaneous tissue in lean and obese men. J Clin Invest 1994;93:240-6.
25. Attvall S, Fowelin J, von Schenck H, Smith U, Lager I. Insulin-antagonistic effects of pulsatile and continuous glucagon infusions in man - a comparison with the effect of adrenaline. J Clin Endocrinol Metab 1992;74:1110-15.
26. Liu D, Moberg E, Kollind M, Lins P-E, Adamsson U, Macdonald IA. Arterial, arterialized venous, venous and capillary blood glucose measurements in normal man during hyperinsulinemic euglycaemia and hypoglycemia. Diabetologia 1992;35:287-90.
27. Bradley DC, Kaslow HR. Radiometric assays for glycerol, glucose, and glycogen. Anal Biochem 1989;180:11-16.
28. Eriksson B-M, Persson B-A. Determination of catecholamines in rat heart tissue and plasma samples by liquid chromatography with electrochemical detection. J Chromatogr 1982;228:143-54.
29. Matthews JNS, Altman DG, Campbell MJ, Royston P. Analysis of serial measurements in medical research. BMJ 1990;300:230-5.
30. Neese RA, Benowitz NL, Hoh R et al. Metabolic interactions between surplus dietary energy intake and cigarette smoking or its cessation. Am J Physiol 1994;267:E1023-34.
31. Clutter WE, Bier DM, Shah SD, Cryer PE. Epinephrine plasma metabolic clearance rates and physiologic thresholds for metabolic and hemodynamic actions in man. J Clin Invest 1980;66:94-101.
32. Galster AD, Clutter WE, Cryer PE, Collins JA. Epinephrine plasma thresholds for lipolytic effects in men. Measurements of fatty acid transport with [1-13C]palmitic acid. J Clin Invest 1981;67:1729-38.
33. Benowitz NL. Pharmacologic aspects of cigarette smoking and nicotine addiction. N Engl J Med 1988;319:1318-30.
34. Kershbaum A, Bellet S, Caplan RF, Feinberg LJ. Effect of cigarette smoking on free fatty acids in patient with healed myocardial infarction. Am J Cardiol 1962;10:204-8.
35. Celermajer DS, Sorensen KE, Georgakopoulos D et al. Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults. Circulation 1993;88:2149-55.
36. Grassi G, Seravalle G, Calhoun DA et al. Mechanisms responsible for sympathetic activation by cigarette smoking in humans. Circulation 1994;90:248-53.
37. Loubatières A, Mariani MM, Sorel G, Savi L. The action of beta-adrenergic blocking and stimulating agents on insulin secretion. Characterization of the type of beta receptor. Diabetologia 1971;7:127-32.
38. Frati AC, Iniestra F, Raul Ariza C. Acute effect of cigarette smoking on glucose tolerance and other cardiovascular risk factors. Diabetes Care 1996;19:112-18.
39. Boden G, Chen X, Ruiz J, White JV, Rossetti L. Mechanisms of fatty acid-induced inhibition of glucose uptake. J Clin Invest 1994;93:2438-46.
40. Reaven GM. The fourth Musketeer - from Alexandre Dumas to Claude Bernard. Diabetologia 1995;38:3-13.
41. Jeppesen J, Hollenbeck CB, Zhou M-Y et al. Relation between insulin resistance, hyperinsulinemia, postheparin plasma lipoprotein lipase activity, and postprandial lipemia. Arterioscler Thromb Vasc Biol 1995;15:320-4.